1.        Introduction

1.1      The Insight Partners Research Report Guidance

1.2      Market Segmentation

2.        Executive Summary

2.1      Key Insights

3.        Research Methodology

3.1      Secondary Research

3.2      Primary Research

3.2.1       Hypothesis formulation:

3.2.2       Macro-economic factor analysis:

3.2.3       Developing base number:

3.2.4       Data Triangulation:

3.2.5       Country level data:

4.        Middle East & Africa Gastrointestinal Drugs Market – Key Market Dynamics

4.1      Market Drivers

4.1.1       Rising Cases of Gastrointestinal Diseases

4.1.2       Increasing Development of Biologics

4.2      Market Restraints

4.2.1       High Cost of Biologics

4.2.2       Average Cost of Biologic Drugs for Severe Ulcerative Colitis or Crohn's Disease

4.3      Market Opportunities

4.3.1       Strategic Initiatives by Companies

4.4      Future Trends

4.4.1       Increasing Research Investment for Novel Drug Development and Artificial Intelligence-Based Techniques

4.5      Impact of Drivers and Restraints:

5.        Gastrointestinal Drugs Market – Middle East & Africa Analysis

5.1      Middle East & Africa Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

6.        Middle East & Africa Gastrointestinal Drugs Market Analysis – by Drug Class

6.1      Biologics

6.1.1       Overview

6.1.2       Biologics: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.2      Antidiarrheal and Laxatives

6.2.1       Overview

6.2.2       Antidiarrheal and Laxatives: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

6.3      Acid Neutralizers

6.3.1       Overview

6.3.2       Acid Neutralizers: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.4      Anti-inflammatory Drugs

6.4.1       Overview

6.4.2       Anti-inflammatory Drugs: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

6.5      Antiemetic and Antinauseants

6.5.1       Overview

6.5.2       Antiemetic and Antinauseants: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

6.6      Others

6.6.1       Overview

6.6.2       Others: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.        Middle East & Africa Gastrointestinal Drugs Market Analysis – by Application

7.1      Irritable Bowel Syndrome

7.1.1       Overview

7.1.2       Irritable Bowel Syndrome: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.2      Inflammatory Ulcerative Colitis

7.2.1       Overview

7.2.2       Inflammatory Ulcerative Colitis: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

7.3      Crohn’s Disease

7.3.1       Overview

7.3.2       Crohn’s Disease: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.4      Gastroenteritis

7.4.1       Overview

7.4.2       Gastroenteritis: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.5      Celiac Disease

7.5.1       Overview

7.5.2       Celiac Disease: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.6      Others

7.6.1       Overview

7.6.2       Others: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.        Middle East & Africa Gastrointestinal Drugs Market Analysis – by Route of Administration

8.1      Oral

8.1.1       Overview

8.1.2       Oral: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.2      Parenteral

8.2.1       Overview

8.2.2       Parenteral: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.        Middle East & Africa Gastrointestinal Drugs Market Analysis – by Distribution Channel

9.1      Hospital Pharmacies

9.1.1       Overview

9.1.2       Hospital Pharmacies: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.2      Retail Pharmacies

9.2.1       Overview

9.2.2       Retail Pharmacies: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.3      Online Pharmacies

9.3.1       Overview

9.3.2       Online Pharmacies: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.      Middle East & Africa Gastrointestinal Drugs Market – Country Analysis

10.1    Middle East & Africa

10.1.1     Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast Analysis – by Country

10.1.1.1       Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.1.1      Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.1.2      Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.1.3      Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.1.4      Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.2       South Africa: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.2.1      South Africa: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.2.2      South Africa: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.2.3      South Africa: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.2.4      South Africa: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.3       United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.3.1      United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.3.2      United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.3.3      United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.3.4      United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Distribution Channel

10.1.1.4       Rest of Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.1.1.4.1      Rest of Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Drug Class

10.1.1.4.2      Rest of Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Application

10.1.1.4.3      Rest of Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Route Of Administration

10.1.1.4.4      Rest of Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.      Industry Landscape

11.1    Overview

11.2    Growth Strategies in Middle East & Africa Gastrointestinal Drugs Market

11.3    Organic Growth Strategies

11.3.1     Overview

11.4    Inorganic Growth Strategies

11.4.1     Overview

12.      Company Profiles

12.1    Sanofi SA

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    GSK Plc

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Johnson & Johnson

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Bausch Health Companies Inc

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    AstraZeneca Plc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Takeda Pharmaceutical Co Ltd

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    AbbVie Inc

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Bayer AG

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Pfizer Inc

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.      Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms

List of Tables

Table 1.          Middle East & Africa Gastrointestinal Drugs Market Segmentation

Table 2.          Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 3.          Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 4.          Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 5.          Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 6.          South Africa: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 7.          South Africa: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 8.          South Africa: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 9.          South Africa: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) –  by Distribution Channel

Table 10.        United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) –  by Drug Class

Table 11.        United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 12.        United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 13.        United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 14.        Rest of Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 15.        Rest of Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 16.        Rest of Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 17.        Rest of Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 18.        Recent Organic Growth Strategies in Middle East & Africa Gastrointestinal Drugs Market

Table 19.        Recent Inorganic Growth Strategies in the Middle East & Africa Gastrointestinal Drugs Market

Table 20.        Glossary of Terms, Middle East & Africa Gastrointestinal Drugs Market

List of Figures

Figure 1.         Middle East & Africa Gastrointestinal Drugs Market Segmentation, by Country

Figure 2.         Middle East & Africa Gastrointestinal Drugs Market – Key Market Dynamics

Figure 3.         Impact Analysis of Drivers and Restraints

Figure 4.         Middle East & Africa Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

Figure 5.         Middle East & Africa Gastrointestinal Drugs Market Share (%) – by Drug Class (2023 and 2031)

Figure 6.         Biologics: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 7.         Antidiarrheal and Laxatives: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.         Acid Neutralizers: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.         Anti-inflammatory Drugs: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.      Antiemetic and Antinauseants: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11.      Others: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.      Middle East & Africa Gastrointestinal Drugs Market Share (%) – by Application (2023 and 2031)

Figure 13.      Irritable Bowel Syndrome: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 14.      Inflammatory Ulcerative Colitis: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.      Crohn’s Disease: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16.      Gastroenteritis: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17.      Celiac Disease: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18.      Others: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.      Middle East & Africa Gastrointestinal Drugs Market Share (%) – by Route Of Administration (2023 and 2031)

Figure 20.      Oral: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 21.      Parenteral: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22.      Middle East & Africa Gastrointestinal Drugs Market Share (%) – by Distribution Channel (2023 and 2031)

Figure 23.      Hospital Pharmacies: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 24.      Retail Pharmacies: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 25.      Online Pharmacies: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26.      Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Key Countries – Revenue (2023) (US$ Million)

Figure 27.      Middle East & Africa Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 28.      Saudi Arabia: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 29.      South Africa: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 30.      United Arab Emirates: Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 31.      Rest of Middle East & Africa Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 32.      Growth Strategies in Middle East & Africa Gastrointestinal Drugs Market